DexForce ranks 9 on the Humanoids 100 with a score of 85; Clone Robotics ranks 87 with 53. DexForce is ahead on deployment, production, commercials, progress, positioning, firepower and leverage. Level on technology. Clone Robotics is based in Mountain View, United States, DexForce in China. Clone Robotics: private. Clone Robotics is named in 24 signals and DexForce in 26.
Clone Robotics develops general-purpose anthropomorphic robots, including the Protoclone and Clone Alpha, with human-like articulation, synthetic organs, pneumatic or hydraulic actuation, and walking capability.
Darker bar: ahead of the other company on that measure.
Clone is the outlier of the humanoid field: instead of motors and gearboxes it builds musculoskeletal androids driven by water-hydraulic artificial muscles ("Myofibers") on a polymer skeleton — the Protoclone V1 has roughly 1,000 muscle fibers and 500 sensors and is the only faithful anatomical replica of the human body in the industry. The bet is that human-shaped compliance and hand dexterity, not payload, wins the home; it markets Clone Alpha as a consumer android on preorder. Commercially it is pre-deployment — no verified customer installations — so its value today is entirely technology option value on a genuinely unique actuation approach the rest of the field cannot copy quickly.
24 signals name Clone Robotics.
16 facts on file.
DexForce develops and sells humanoid robots, including the 40-degree-of-freedom W1 Pro, and has shipped thousands of robots for real-world deployments in tourism, cultural venues, retail and service settings.
Darker bar: ahead of the other company on that measure.
DexForce, also known as Kuawei or 跨维智能, is a China-based physical-AI company supplying embodied-intelligence software, 3D perception, simulation/data infrastructure and its own W1 Pro general-purpose humanoid platform. It reported more than 1,000 deployed projects across over 30 cities, a July-2025 A1/A2 financing of several hundred million RMB, a June-2026 RMB 1 billion Series B at a valuation above RMB 10 billion, and W1 Pro production and first delivery through Lenovo's manufacturing network in October-December 2025. Its distinguishing position is a vertically integrated data-to-model-to-robot stack; the open question is how much of reported commercial deployment is autonomous operation versus company-supported or teleoperated delivery.
26 signals name DexForce.
50 facts on file.
DexForce ranks 9 on the Humanoids 100 with a score of 85; Clone Robotics ranks 87 with 53. DexForce is ahead on deployment, production, commercials, progress, positioning, firepower and leverage. Level on technology. Clone Robotics is based in Mountain View, United States, DexForce in China. Clone Robotics: private. Clone Robotics is named in 24 signals and DexForce in 26.
DexForce ranks 9 on the Humanoids 100 with a score of 85; Clone Robotics ranks 87 with 53. DexForce is ahead on deployment, production, commercials, progress, positioning, firepower and leverage. Level on technology. Clone Robotics is based in Mountain View, United States, DexForce in China. Clone Robotics: private. Clone Robotics is named in 24 signals and DexForce in 26. Both company files carry the scores on eight measures, the facts with sources and the latest signals.
Members see every signal and fact behind both companies, the live ranking, the questions the signals answer and the week explained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →